BRCAVANTAGETM COMPREHENSIVE

BRCAVANTAGETM COMPREHENSIVE

Test Code 91863

 

CPT Code(s) 81211, 81213

 

Physician Attestation of Informed Consent

 

This germline genetic test requires physician attestation that patient consent has been received if ordering medical facility is located in AK, AZ, DE, FL, GA, MA, MN, NV, NH, NJ, NM, NY, OR, SD or VT or test is performed in MA.

 

Includes

 

BRCA1 Sequencing, BRCA1 Deletion/Duplication, BRCA2 Sequencing, BRCA2 Deletion/Duplication, Comprehensive Interpretation

 

Methodology

 

Next Generation Sequencing • Multiplex Ligation-dependent Probe Amplification (MLPA)

 

Reference Range(s)

 

See Laboratory Report

 

Clinical Significance

 

This test detects mutations in the BRCA1 and BRCA2 genes which are the most common causes of hereditary breast and ovarian cancers.

Alternative Name(s)

BRCA1 and BRCA2 Comprehensive Panel, BRCA1 Comprehensive Panel, BRCA2 Sequencing, Genetic Breast Cancer, Hereditary Ovarian Cancer, BRCA1 Sequencing,BRCA1 Deletion/Duplication, BRCA1 and BRCA2 Deletion/Duplication, BRCA2 Deletion/Duplication, Hereditary Breast Cancer, BRCA2 Comprehensive Panel